Potential consequences of the pneumococcal conjugate vaccine [1]

New England Journal of Medicine

Volumn 355, Issue 1, 2006, Pages 95-

  Kopterides, Petros ^a   Falagas, Matthew E ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; DISEASE CONTROL; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION;

DRUG RESISTANCE, BACTERIAL; HUMANS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 33745698678     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc061220     Document Type: Letter

References (5)

1. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354:1455-63.
2. Regev-Yochay G, Dagan R, Raz M, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 2004;292:716-20.
3. Bogaert D, van Belkum A, Sluijter M, et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004;363:1871-2.
4. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003;361:2189-95.
5. Moellering RC Jr. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med 2006;144:368-70.